Purpose: This 5-year, prospective, multicenter trial evaluated the long-term safety and efficacy of sacral neuromodulation in patients with refractory urge incontinence, urgency frequency and retention.

Materials And Methods: A total of 17 centers worldwide enrolled 163 patients (87% female). Following test stimulation 11 patients declined implantation and 152 underwent implantation using InterStim. Of those treated with implantation 96 (63.2%) had urge incontinence, 25 (16.4%) had urgency frequency and 31 (20.4%) had retention. Voiding diaries were collected annually for 5 years. Clinical success was defined as 50% or greater improvement from baseline in primary voiding diary variable(s).

Results: Data for all implanted cases were reported. For patients with urge incontinence mean leaking episodes per day decreased from 9.6 +/- 6.0 to 3.9 +/- 4.0 at 5 years. For patients with urgency frequency mean voids per day decreased from 19.3 +/- 7.0 to 14.8 +/- 7.6, and mean volume voided per void increased from 92.3 +/- 52.8 to 165.2 +/- 147.7 ml. For patients with retention the mean volume per catheterization decreased from 379.9 +/- 183.8 to 109.2 +/- 184.3 ml, and the mean number of catheterizations decreased from 5.3 +/- 2.8 to 1.9 +/- 2.8. All changes were statistically significant (p <0.001). No life threatening or irreversible adverse events occurred. In 102 patients 279 device or therapy related adverse events were observed. At 5 years after implantation 68% of patients with urge incontinence, 56% with urgency frequency and 71% with retention had successful outcomes.

Conclusions: This long-term study demonstrates that InterStim therapy is safe and effective for restoring voiding in appropriately selected cases refractory to other forms of treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2007.07.032DOI Listing

Publication Analysis

Top Keywords

urge incontinence
12
urgency frequency
12
+/-
10
sacral neuromodulation
8
day decreased
8
decreased +/-
8
+/- +/-
8
patients
6
neuromodulation therapy
4
therapy urinary
4

Similar Publications

Purpose: Neurogenic lower urinary tract dysfunction (NLUTD) is highly prevalent among patients with neurologic disorders. Some studies have demonstrated that implantable neuromodulation can improve symptoms of NLUTD. We seek to describe our experience with sacral and pudendal neuromodulation in patients with NLUTD.

View Article and Find Full Text PDF
Article Synopsis
  • Urinary incontinence, especially urge urinary incontinence (UUI), affects many people as they age, impacting their quality of life, and this study explores its relationship with dietary antioxidants (CDAI).
  • Using data from 7,735 participants, the research found that lower CDAI levels were negatively associated with UUI prevalence, particularly significant in males with low antioxidant diets, while a strong negative link was also noted with zinc levels.
  • The study concluded that improving dietary antioxidants could be crucial for preventing or treating UUI in men, especially those with low CDAI levels.
View Article and Find Full Text PDF

Bladder health in U.S. Shift Workers: A Cross-Sectional Study (NHANES).

Urol J

December 2024

Department of Urology, The 3rd Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, China.

Purpose: Working during non-traditional hours is becoming more prevalent in modern societies and presents a significant hurdle to an individual's circadian rhythm. We examined the bladder health of shift workers in the United States by analyzing information obtained from the National Health and Nutrition Examination Survey.

Materials And Methods: National Health and Nutrition Examination Survey (NHANES) datasets from 2005 to 2010 were utilized.

View Article and Find Full Text PDF

Introduction: Detrusor contractions can be classified as either volitional or involuntary. The latter are a hallmark of urge urinary incontinence. Understanding differences in neuroactivation associated with both types of contractions can help elucidate pathophysiology and therapeutic targets.

View Article and Find Full Text PDF

Urogynecologic Care for Women Who Are Incarcerated.

Urogynecology (Phila)

October 2024

Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI.

In the United States, approximately 180,700 women are incarcerated across jails and prisons, comprising a demographic with an aging population and a higher growth rate compared to men. Despite this demographic trend, research into urogynecologic care for women who are incarcerated is notably lacking, with few studies addressing pelvic floor disorders such as incontinence, and even fewer focusing on access to treatment options like vaginal pessaries or surgical interventions. Women who are incarcerated may face unique challenges in obtaining urogynecologic care, including limited access to medical evaluations, invasive search procedures affecting intravaginal device use, and inadequate hygiene resources, all of which hinder effective management strategies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!